The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1487
February 1, 2016
View Complete Issue         Table of Contents 2019 
Drugs for Rosacea
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Rosacea
February 1, 2016 (Issue: 1487)
This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops of acneiform papules and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Rosacea
Article code: 1487b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.